Who owns Atyr Pharma Inc?
- Ticker: LIFE
- CUSIP Number: 002120202
Tip: Access positions for across all investors
Analyze quarterly positions in Atyr Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atyr Pharma stock
Who bought or sold Atyr Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 10M | $14M | 0% | Dec 2023 |
|
| FMR | 8.9M | $17M | 4% | Mar 2024 |
|
| Logos Global Management | 3.1M | $6.0M | -47% | Mar 2024 |
|
| Vanguard Group | 2.7M | $5.2M | 12% | Mar 2024 |
|
| Citadel Advisors | 1.9M | $3.7M | 9% | Mar 2024 |
|
| Woodline Partners | 1.7M | $3.3M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 1.5M | $2.9M | -39% | Mar 2024 |
|
| Checkpoint Capital | 1.4M | $2.8M | -4% | Mar 2024 |
|
| BlackRock | 1.4M | $2.7M | 1% | Mar 2024 |
|
| Octagon Capital Advisors | 700k | $1.4M | 100% | Mar 2024 |
|
| Barclays | 604k | $1.2M | 665% | Mar 2024 |
|
| Geode Capital Management | 595k | $1.2M | 1% | Mar 2024 |
|
| Tang Capital Management | 471k | $919k | 0% | Mar 2024 |
|
| GSA Capital Partners | 224k | $437k | 105% | Mar 2024 |
|
| Goldman Sachs Group | 217k | $424k | 51% | Mar 2024 |
|
| Dimensional Fund Advisors | 197k | $384k | 38% | Mar 2024 |
|
| Marshall Wace | 159k | $309k | 100% | Mar 2024 |
|
| Bank of America Corporation | 156k | $305k | 5% | Mar 2024 |
|
| Two Sigma Advisers | 142k | $278k | -4% | Mar 2024 |
|
| Northern Trust | 99k | $193k | 26% | Mar 2024 |
|
| XTX Topco | 83k | $163k | 13% | Mar 2024 |
|
| Citigroup | 79k | $153k | 0% | Mar 2024 |
|
| Millennium Management | 63k | $122k | -50% | Mar 2024 |
|
| Jane Street | 62k | $121k | 100% | Mar 2024 |
|
| Kingswood Wealth Advisors | 60k | $117k | 100% | Mar 2024 |
|
| American Century Companies | 54k | $105k | 145% | Mar 2024 |
|
| Acadian Asset Management | 45k | $87k | 100% | Mar 2024 |
|
| Y-Intercept | 44k | $86k | 100% | Mar 2024 |
|
| Main Street Financial Solutions | 35k | $67k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 34k | $66k | 185% | Mar 2024 |
|
| Farther Finance Advisors | 30k | $58k | 0% | Mar 2024 |
|
| SG Americas Securities | 28k | $55k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 27k | $52k | 0% | Mar 2024 |
|
| Virtu Financial | 26k | $37k | 93% | Dec 2023 |
|
| D.A. Davidson & Co. | 26k | $51k | 107% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 21k | $40k | 100% | Mar 2024 |
|
| UBS Group | 20k | $39k | 23% | Mar 2024 |
|
| Morgan Stanley | 20k | $39k | 720% | Mar 2024 |
|
| CTC Alternative Strategies | 18k | $34k | 100% | Mar 2024 |
|
| Two Sigma Securities | 18k | $34k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 16k | $31k | -83% | Mar 2024 |
|
| Cubist Systematic Strategies | 12k | $23k | -33% | Mar 2024 |
|
| Two Sigma Investments | 10k | $20k | -62% | Mar 2024 |
|
| Actinver Wealth Management | 10k | $20k | 0% | Mar 2024 |
|
| Qube Research & Technologies | 9.6k | $19k | 5030% | Mar 2024 |
|
| Tower Research Capital | 6.3k | $12k | 819% | Mar 2024 |
|
| Simplex Trading | 6.0k | $11k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 1.9k | $3.7k | 0% | Mar 2024 |
|
| PFS Partners | 340.00 | $663.000000 | 0% | Mar 2024 |
|
| Caldwell Sutter Capital | 52.00 | $100.999600 | 0% | Mar 2024 |
|
Who sold out of Atyr Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Dec 2023 | 120k | $168k |
| Boothbay Fund Management | Sep 2023 | 36k | $57k |
| Granite Bay Wealth Management | Dec 2023 | 18k | $22k |
| Bank of New York Mellon | Dec 2023 | 16k | $23k |